Byrne Asset Management LLC Myriad Genetics Inc Transaction History

Byrne Asset Management LLC

  • $134 Million
  • Q3 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
SELL
$13.17 - $27.03 $2,634 - $5,406
-200 Reduced 80.0%
50 $0
Q3 2024

Jan 29, 2025
BUY
$23.97 - $28.6 $4,794 - $5,720
200 Added 400.0%
250 $6,000
Q3 2024

Jan 28, 2025
BUY
$23.97 - $28.6 $4,794 - $5,720
200 Added 400.0%
250 $6,000
Q4 2023

Jan 29, 2024
SELL
$13.91 - $21.32 $3,477 - $5,330
-250 Reduced 50.0%
250 $4,000
Q2 2023

Jul 21, 2023
BUY
$17.56 - $23.76 $8,780 - $11,880
500 New
500 $11,000

Others Institutions Holding MYGN

# of Institutions
239
Shares Held
91.9M
Call Options Held
86.1K
Put Options Held
18.9K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $541M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Byrne Asset Management LLC Portfolio

Follow Byrne Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email